Cargando…
Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review
Cholangiocarcinoma (CCA) is a rare cancer originating from the biliary epithelium and accounts for about 3% of all gastrointestinal malignancies. Unfortunately, the majority of patients are not eligible for surgical resection at the time of diagnosis, because of the locally advanced stage or metasta...
Autores principales: | Di Girolamo, Elena, Belli, Andrea, Ottaiano, Alessandro, Granata, Vincenza, Borzillo, Valentina, Tarotto, Luca, Tatangelo, Fabiana, Palaia, Raffaele, Civiletti, Corrado, Piccirillo, Mauro, D’Angelo, Valentina, Fiore, Francesco, Marone, Pietro, Nasti, Guglielmo, Izzo, Francesco, de Bellis, Mario |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266199/ https://www.ncbi.nlm.nih.gov/pubmed/37324013 http://dx.doi.org/10.3389/fonc.2023.1077794 |
Ejemplares similares
-
Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review
por: Patrone, Renato, et al.
Publicado: (2021) -
Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022) -
Correction: Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022) -
The safety and efficacy of Glubran 2 as biliostatic agent in liver resection
por: Patrone, Renato, et al.
Publicado: (2021) -
Endobiliary Radiofrequency Ablation Combined with Gemcitabine and Cisplatin in Patients with Unresectable Extrahepatic Cholangiocarcinoma
por: Inoue, Tadahisa, et al.
Publicado: (2022)